Browsing Tag
bipolar depression
3 posts
FDA approves JNJ’s CAPLYTA for depression: Is this a new hope for MDD remission?
Johnson & Johnson secures FDA approval for CAPLYTA in major depressive disorder. Find out how this expands safe treatment options for difficult-to-treat depression.
November 6, 2025
Understanding Depression Symptoms, Types, and Implications
Depression is a pervasive psychiatric condition recognized as a leading cause of disability worldwide. It spans a spectrum…
June 15, 2024
Lupin launches Lurasidone Hydrochloride in US, targeting $4.2bn bipolar depression market
Lupin launches Lurasidone Hydrochloride Tablets in the US, entering a $4.2B bipolar depression market with a full range of strengths.
February 22, 2023